AngioDynamics, Inc. (ANGO) Current Ratio
- Current ratio · latest quarter: Value 2.19×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.19× | Current assets / current liabilities. $163.39M ÷ $74.72M ≈ 2.19× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 163.39M USD | Assets, Current |
| Current obligations | 74.72M USD | Liabilities, Current |
| Cash and equivalents | 53.86M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Customer receivables | 48.33M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 52.44M USD | Inventory, Net |
| Payables | 31.51M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $163.39M | $74.72M | $53.86M | (m) | $48.33M | $52.44M | $31.51M | (m) | 2.19× |
| 2026-02-28 | $155.55M | $66.07M | $37.81M | (m) | $45.55M | $58.58M | $29.11M | (m) | 2.35× |
| 2025-11-30 | $161.35M | $71.96M | $41.64M | (m) | $44.43M | $65.57M | $35.39M | (m) | 2.24× |
| 2025-08-31 | $156.66M | $68.28M | $38.76M | (m) | $42.64M | $62.26M | $31.88M | (m) | 2.29× |
| 2025-05-31 | $168.32M | $76.20M | $55.89M | (m) | $42.89M | $62.01M | $33.29M | (m) | 2.21× |
| 2025-02-28 | $172.27M | $77.97M | $44.76M | (m) | $43.47M | $63.10M | $30.27M | (m) | 2.21× |
| 2024-11-30 | $175.36M | $88.59M | $54.09M | (m) | $43.16M | $65.92M | $34.75M | (m) | 1.98× |
| 2024-08-31 | $172.59M | $76.70M | $55.01M | (m) | $39.56M | $64.70M | $31.27M | (m) | 2.25× |
| 2024-05-31 | $193.25M | $91.16M | $76.06M | (m) | $43.61M | $60.62M | $37.75M | (m) | 2.12× |
| 2024-02-29 | $196.91M | $85.87M | $78.45M | (m) | $49.48M | $58.07M | $35.15M | (m) | 2.29× |
| 2023-11-30 | $185.47M | $78.04M | $60.90M | (m) | $51.60M | $64.25M | $37.65M | (m) | 2.38× |
| 2023-08-31 | $175.47M | $57.45M | $57.59M | (m) | $49.76M | $59.97M | $24.81M | (m) | 3.05× |
| 2023-05-31 | $163.54M | $83.83M | $44.62M | (m) | $52.83M | $55.33M | $40.45M | (m) | 1.95× |
| 2023-02-28 | $152.57M | $69.63M | $30.11M | (m) | $50.89M | $63.53M | $35.60M | (m) | 2.19× |
| 2022-11-30 | $158.83M | $73.57M | $29.86M | (m) | $52.85M | $63.18M | $34.69M | (m) | 2.16× |
| 2022-08-31 | $151.37M | $66.39M | $24.56M | (m) | $53.59M | $57.61M | $29.26M | (m) | 2.28× |
| 2022-05-31 | $143.34M | $74.32M | $28.82M | (m) | $52.30M | $51.39M | $28.05M | (m) | 1.93× |
| 2022-02-28 | $127.69M | $49.37M | $23.89M | (m) | $41.81M | $48.04M | $21.57M | (m) | 2.59× |
| 2021-11-30 | $132.19M | $54.48M | $34.29M | (m) | $38.20M | $48.18M | $24.19M | (m) | 2.43× |
| 2021-08-31 | $131.32M | $52.10M | $35.47M | (m) | $35.42M | $49.30M | $22.69M | (m) | 2.52× |
| 2021-05-31 | $140.88M | $57.58M | $48.16M | (m) | $35.41M | $48.61M | $19.63M | (m) | 2.45× |
| 2021-02-28 | $145.66M | $50.26M | $54.47M | (m) | $33.17M | $49.01M | $17.07M | (m) | 2.90× |
| 2020-11-30 | $149.70M | $45.81M | $58.02M | (m) | $33.60M | $49.58M | $15.98M | (m) | 3.27× |
| 2020-08-31 | $142.24M | $39.85M | $47.93M | (m) | $33.59M | $52.76M | $14.01M | (m) | 3.57× |
| 2020-05-31 | $152.91M | $51.45M | $54.44M | (m) | $31.26M | $59.91M | $19.10M | (m) | 2.97× |
| 2020-02-29 | $129.05M | $48.71M | $27.16M | (m) | $35.62M | $54.90M | $18.30M | $0.00 | 2.65× |
| 2019-11-30 | $131.98M | $57.01M | $41.25M | (m) | $33.99M | $50.24M | $17.97M | $0.00 | 2.32× |
| 2019-08-31 | $166.36M | $47.17M | $83.65M | (m) | $32.54M | $45.23M | $16.87M | $0.00 | 3.53× |
| 2019-05-31 | $315.29M | $73.30M | $227.64M | (m) | $43.58M | $40.07M | $22.83M | $7.50M | 4.30× |
| 2019-02-28 | $142.74M | $53.30M | $41.70M | $0.00 | $44.21M | $52.39M | $18.44M | $6.25M | 2.68× |
| 2018-11-30 | $142.96M | $49.70M | $42.82M | $1.35M | $43.37M | $50.64M | $19.42M | $5.00M | 2.88× |
| 2018-08-31 | $120.89M | $45.79M | $24.76M | $1.35M | $40.16M | $49.72M | $16.92M | $5.00M | 2.64× |
| 2018-05-31 | $168.03M | $57.30M | $74.10M | $1.32M | $39.40M | $39.27M | $15.78M | $5.00M | 2.93× |
| 2018-02-28 | $156.57M | $54.40M | $52.29M | $1.28M | $41.83M | $56.56M | $16.35M | $5.00M | 2.88× |
| 2017-11-30 | $152.50M | $59.66M | $49.86M | $1.26M | $42.07M | $54.03M | $21.80M | $5.00M | 2.56× |
| 2017-08-31 | $150.72M | $64.32M | $48.20M | $1.22M | $41.28M | $55.42M | $17.42M | $5.00M | 2.34× |
| 2017-05-31 | $153.91M | $71.52M | $47.54M | $1.22M | $44.52M | $54.51M | $18.09M | $5.00M | 2.15× |
| 2017-02-28 | $145.05M | $50.64M | $35.57M | $1.20M | $46.30M | $57.68M | $15.36M | $5.00M | 2.86× |
| 2016-11-30 | $147.80M | $50.75M | $35.66M | $1.20M | $50.17M | $56.67M | $15.29M | $5.00M | 2.91× |
| 2016-08-31 | $152.28M | $65.43M | $37.41M | $1.65M | $50.12M | $58.27M | $15.65M | $17.50M | 2.33× |
| 2016-05-31 | $146.25M | $66.73M | $32.33M | $1.65M | $52.87M | $55.37M | $15.62M | $16.25M | 2.19× |
| 2015-05-31 | $150.80M | $60.52M | $18.39M | $1.69M | $58.43M | $67.39M | $23.05M | $8.75M | 2.49× |
| 2015-02-28 | $154.49M | $59.50M | (m) | (m) | (m) | $68.77M | $21.97M | (m) | 2.60× |
| 2014-11-30 | $159.22M | $57.10M | (m) | (m) | (m) | $75.37M | (m) | (m) | 2.79× |
| 2014-08-31 | $151.21M | $63.35M | (m) | (m) | (m) | $71.31M | (m) | (m) | 2.39× |
| 2014-05-31 | $147.01M | $65.94M | $16.11M | (m) | (m) | $61.74M | (m) | (m) | 2.23× |
| 2014-02-28 | $140.13M | $63.38M | $7.38M | $1.81M | $57.73M | $59.83M | $25.51M | $5.00M | 2.21× |
| 2013-11-30 | $141.57M | $69.08M | $15.17M | $1.85M | $48.41M | $60.05M | $28.34M | $5.00M | 2.05× |
| 2013-08-31 | $145.23M | $74.36M | $22.07M | $1.85M | $46.56M | $59.25M | $26.70M | $13.13M | 1.95× |
| 2013-02-28 | $146.44M | $66.83M | $16.63M | $2.15M | $45.11M | $61.97M | $23.66M | $7.50M | 2.19× |
| 2012-11-30 | $151.46M | $60.38M | $19.32M | $2.15M | $47.09M | $62.33M | $20.95M | $7.50M | 2.51× |
| 2012-08-31 | $160.59M | $52.38M | $18.90M | $11.63M | $45.43M | $63.41M | $24.43M | $7.50M | 3.07× |
| 2012-05-31 | $157.76M | $53.77M | $23.74M | (m) | $46.90M | (m) | (m) | (m) | 2.93× |
| 2012-02-29 | $211.05M | $29.19M | $34.05M | $108.98M | $26.72M | $28.16M | $16.54M | $295.00K | 7.23× |
| 2011-11-30 | $205.84M | $26.62M | $42.95M | $93.36M | $31.45M | $29.43M | $11.81M | $290.00K | 7.73× |
| 2011-08-31 | $199.87M | $24.11M | $50.49M | $86.16M | $26.36M | $29.67M | $10.73M | $285.00K | 8.29× |
| 2011-05-31 | $194.18M | $25.40M | $45.98M | (m) | $27.01M | (m) | (m) | (m) | 7.64× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |